Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(2):349-351 | DOI: 10.5507/bp.2007.060
HAEMOTHERAPY ANALYSIS: THE TEACHING HOSPITAL OLOMOUC IN 2006
- a Department of Blood Transfusion, Teaching Hospital, Palacky University, Olomouc, Czech Republic
- b Ist Department of Internal Medicine, Teaching Hospital, Palacky University, Olomouc
- e-mail: Dana.Galuszkova@fnol.cz
Aims: Annual evaluation of blood transfusion preparation administration at the University Hospital Olomouc, Czech Republic as a contribution to the European Union haemovigilance system.
Methods: Analysis of blood transfusion preparations released from the Department of Blood Transfusion of the above university hospital and laboratory examination results in receivers of these products for the year 2006. Total hospital consumption and usage in particular medical disciplines in the hospital were assessed.
Results: Red cell concentrates: in total 14 347 TU (deleucotised in 20.4 %). Departments according to usage: surgery, haematooncology, anaesthesiology and surgery intensive care department, and internal medicine department. Haemoglobin levels were above 100 g/L before blood transfusion administration in 24 % of cases. Platelets: in total 1 712 TU (100 % manufactured by apheresis, 56 % deleucotised). Platelet counts below 20 x 109/L were found in all cases before platelet concentrate administration. Plasma: in total 5 959 TU to 1 297 of patients. Departments according to usage: surgery, anaesthesiology and surgery intensive care department, internal medicine and haematooncology. Two hundred and forty nine cases without coagulation parameter monitoring and 333 (25.67 %) patients with only 1 TU of administered plasma were found.
Conclusions: The incorrect indications for red cell transfusion preparations were found in eleven patients with haemoglobin levels above 130 g/L. Underdosing in 25.67 % of plasma administrations signifies dubious indications in these cases. Implementation of the haemovigilance system in practice is now mandatory for the Czech Republic after joining the European Union. Therefore more precise data and analysis of questionable cases with further education of staff in clinical departments are essential for the haemovigilance principle to be applied on a hospital basis in the Czech Republic.
Keywords: Haemotherapy, Blood transfusion, Haemovigilance
Received: September 12, 2007; Accepted: October 15, 2007; Published: December 1, 2007 Show citation
References
- Commission directive 2005/61/EC of 30 September 2005 implementing Direction 2002/98/EC of the European Parliament and of the Council as regards traceability requirements and notifi cation of serious adverse reactions and events. In: Offi cial Journal of the European Union 1. 10. 2005: L 256/32-40
- Commission directive 2005/62/EC of 30 September 2005 implementing Direction 2002/98/ES of the European Parliament and of the Council as regards community standards and specifi cations relating to a quality system for blood establishments. In: Offi cial Journal of the European Union 1. 10. 2005: L 256/41-48
- Vyhláška ze dne 21. června 2004, kterou se stanoví správná výrobní praxe, správná distribuční praxe a bližší podmínky povolování výroby a distribuce léčiv, včetně medikovaných krmiv a veterinárních autogenních vakcín, změn vydaných povolení, jakož i bližší podmínky vydávání povolení k činnosti kontrolních laboratoří (vyhláška o výrobě a distribuci léčiv). In: Sbírka zákonů č. 411/2004, strana 7962, částka 133
- Guide to the preparation, use and quality assurance of blood components, Recommendation No. R 95) 15, 13th edition. Council of Europe Publishing, January 2007